-
2
-
-
79551603829
-
Characterisation of COPD heterogeneity in the ECLIPSE cohort
-
Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res 2010; 11: 122.
-
(2010)
Respir Res
, vol.11
, pp. 122
-
-
Agusti, A.1
Calverley, P.M.2
Celli, B.3
-
3
-
-
80053534329
-
Avoiding confusion in COPD: From risk factors to phenotypes to measures of disease characterisation
-
Agusti A, Celli B. Avoiding confusion in COPD: from risk factors to phenotypes to measures of disease characterisation. Eur Respir J 2011; 38: 749-751.
-
(2011)
Eur Respir J
, vol.38
, pp. 749-751
-
-
Agusti, A.1
Celli, B.2
-
4
-
-
77957705828
-
Chronic obstructive pulmonary disease phenotypes: The future of COPD
-
Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010; 182: 598-604.
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 598-604
-
-
Han, M.K.1
Agusti, A.2
Calverley, P.M.3
-
5
-
-
2442571198
-
The British hypothesis revisited
-
Anthonisen NR. The British hypothesis revisited. Eur Respir J 2004; 23: 657-658.
-
(2004)
Eur Respir J
, vol.23
, pp. 657-658
-
-
Anthonisen, N.R.1
-
6
-
-
0017402583
-
The natural history of chronic airflow obstruction
-
Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648.
-
(1977)
BMJ
, vol.1
, pp. 1645-1648
-
-
Fletcher, C.1
Peto, R.2
-
7
-
-
0029947193
-
Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity
-
Copenhagen City Heart Study Group
-
Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996; 153: 1530-1535.
-
(1996)
Am J Respir Crit Care Med
, vol.153
, pp. 1530-1535
-
-
Vestbo, J.1
Prescott, E.2
Lange, P.3
-
8
-
-
0035422691
-
Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: Results from the lung health study
-
Kanner RE, Anthonisen NR, Connett JE. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study. Am J Respir Crit Care Med 2001; 164: 358-364.
-
(2001)
Am J Respir Crit Care Med
, vol.164
, pp. 358-364
-
-
Kanner, R.E.1
Anthonisen, N.R.2
Connett, J.E.3
-
9
-
-
26244444367
-
Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis
-
Ekberg-Aronsson M, Pehrsson K, Nilsson JA, et al. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005; 6: 98-107.
-
(2005)
Respir Res
, vol.6
, pp. 98-107
-
-
Ekberg-Aronsson, M.1
Pehrsson, K.2
Nilsson, J.A.3
-
10
-
-
0025033561
-
Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes
-
Lange P, Nyboe J, Appleyard M, et al. Relation of ventilatory impairment and of chronic mucus hypersecretion to mortality from obstructive lung disease and from all causes. Thorax 1990; 45: 579-585.
-
(1990)
Thorax
, vol.45
, pp. 579-585
-
-
Lange, P.1
Nyboe, J.2
Appleyard, M.3
-
11
-
-
33750048426
-
Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: A follow-up in middleaged rural men
-
Pelkonen M, Notkola IL, Nissinen A, et al. Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middleaged rural men. Chest 2006; 130: 1129-1137.
-
(2006)
Chest
, vol.130
, pp. 1129-1137
-
-
Pelkonen, M.1
Notkola, I.L.2
Nissinen, A.3
-
12
-
-
0033781008
-
Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: A multiple logistic regression analysis
-
Miravitlles M, Guerrero T, Mayordomo C, et al. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. Respiration 2000; 67: 495-501.
-
(2000)
Respiration
, vol.67
, pp. 495-501
-
-
Miravitlles, M.1
Guerrero, T.2
Mayordomo, C.3
-
13
-
-
0031746535
-
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease
-
Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-1422.
-
(1998)
Am J Respir Crit Care Med
, vol.157
, pp. 1418-1422
-
-
Seemungal, T.A.1
Donaldson, G.C.2
Paul, E.A.3
-
14
-
-
84862491658
-
The chronic bronchitis phenotype in subjects with and without COPD: The PLATINO study
-
Montes de Oca M, Halbert RJ, Lopez MV, et al. The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J 2012; 40: 28-36.
-
(2012)
Eur Respir J
, vol.40
, pp. 28-36
-
-
Montes De Oca, M.1
Halbert, R.J.2
Lopez, M.V.3
-
15
-
-
64749104557
-
Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects
-
Burgel PR, Nesme-Meyer P, Chanez P, et al. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest 2009; 135: 975-982.
-
(2009)
Chest
, vol.135
, pp. 975-982
-
-
Burgel, P.R.1
Nesme-Meyer, P.2
Chanez, P.3
-
16
-
-
80052690031
-
The chronic bronchitic phenotype of COPD: An analysis of the COPDGene study
-
Kim V, Han MLK, Vance GB, et al. The chronic bronchitic phenotype of COPD: an analysis of the COPDGene study. Chest 2011; 140: 626-633.
-
(2011)
Chest
, vol.140
, pp. 626-633
-
-
Kim, V.1
Han, M.L.K.2
Vance, G.B.3
-
17
-
-
77957278202
-
Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China
-
Lu M, Yao WZ, Zhong NS, et al. Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China. Respirology 2010; 15: 1072-1078.
-
(2010)
Respirology
, vol.15
, pp. 1072-1078
-
-
Lu, M.1
Yao, W.Z.2
Zhong, N.S.3
-
18
-
-
0029150812
-
Chronic mucus hypersecretion in COPD and death from pulmonary infection
-
Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995; 8: 1333-1338.
-
(1995)
Eur Respir J
, vol.8
, pp. 1333-1338
-
-
Prescott, E.1
Lange, P.2
Vestbo, J.3
-
19
-
-
0036682945
-
Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease?
-
Vestbo J, Lange P. Can GOLD stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002; 166: 329-332.
-
(2002)
Am J Respir Crit Care Med
, vol.166
, pp. 329-332
-
-
Vestbo, J.1
Lange, P.2
-
20
-
-
77956689733
-
Susceptibility to exacerbation in chronic obstructive pulmonary disease
-
Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138.
-
(2010)
N Engl J Med
, vol.363
, pp. 1128-1138
-
-
Hurst, J.R.1
Vestbo, J.2
Anzueto, A.3
-
21
-
-
34447310046
-
Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease
-
Calverley PMA, Sanchez-Torill F, McIvor A, et al. Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: 154-161.
-
(2007)
Am J Respir Crit Care Med
, vol.176
, pp. 154-161
-
-
Calverley, P.M.A.1
Sanchez-Torill, F.2
McIvor, A.3
-
22
-
-
79251588730
-
Reduction of exacerbations by the PDE4 inhibitor roflumilast - The importance of defining different subsets of patients with COPD
-
Rennard SI, Calverley PMA, Goehring UM, et al. Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD. Respir Res 2011; 12: 18.
-
(2011)
Respir Res
, vol.12
, pp. 18
-
-
Rennard, S.I.1
Calverley, P.M.A.2
Goehring, U.M.3
-
23
-
-
77952490797
-
Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: A randomized controlled trial
-
Sethi S, Jones PW, Theron MS, et al. Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Respir Res 2010; 11: 10.
-
(2010)
Respir Res
, vol.11
, pp. 10
-
-
Sethi, S.1
Jones, P.W.2
Theron, M.S.3
-
24
-
-
69149103642
-
Roflumilast in symptomatic chronic obstructive pulmonary disease: Two randomised clinical trials
-
Calverley PM, Rabe KF, Goehring UM, et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009; 374: 685-694.
-
(2009)
Lancet
, vol.374
, pp. 685-694
-
-
Calverley, P.M.1
Rabe, K.F.2
Goehring, U.M.3
-
25
-
-
79959362446
-
Complex systems in pulmonary medicine: A systems biology approach to lung disease
-
Kaminsky DA, Irvin CG, Sterk PJ. Complex systems in pulmonary medicine: a systems biology approach to lung disease. J Appl Physiol 2011; 110: 1716-1722.
-
(2011)
J Appl Physiol
, vol.110
, pp. 1716-1722
-
-
Kaminsky, D.A.1
Irvin, C.G.2
Sterk, P.J.3
-
26
-
-
77953389042
-
Clinical COPD phenotypes: A novel approach using principal component and cluster analyses
-
Burgel PR, Paillasseur JL, Caillaud D, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010; 36: 531-539.
-
(2010)
Eur Respir J
, vol.36
, pp. 531-539
-
-
Burgel, P.R.1
Paillasseur, J.L.2
Caillaud, D.3
-
27
-
-
69249098135
-
Distinct clinical phenotypes of airways disease defined by cluster analysis
-
Weatherall M, Travers J, Shirtcliffe PM, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J 2009; 34: 812-818.
-
(2009)
Eur Respir J
, vol.34
, pp. 812-818
-
-
Weatherall, M.1
Travers, J.2
Shirtcliffe, P.M.3
|